New research from Washington University School of Medicine in St. Louis indicates that younger adults are biologically aging faster than older cohorts, a shift that appears linked to rising rates of early‑onset cancers.
Age gaps are widening.
Study finds larger “age gap” in recent birth cohorts
Scientists examined more than 154,000 participants from the UK Biobank and over 10,000 individuals in the U.S. All of Us Research Program. By comparing biological age—estimated through blood biomarkers, metabolomic scores and organ‑specific protein panels—to chronological age, they calculated an “age gap” for each participant. The gap measures how much older a person’s body seems compared with their actual years lived.
Accelerated aging tied to higher cancer risk
Organ‑specific findings showed that an immune system appearing older than its chronological age correlated with early‑onset lung cancer, while older‑appearing adipose tissue was associated with early‑onset colorectal cancer. These results hint that different organ systems may age at distinct rates, influencing cancer development in subtle ways.
While the study does not pinpoint a single cause, the authors suggest that modern environmental and lifestyle factors could be embedding themselves biologically, speeding up aging processes. If future work confirms that certain exposures—such as poor diet or sedentary habits—leave lasting marks on organ health, targeted prevention might become possible.
Related: Wildfire smoke reduces New York bird sightings
Implications for screening and prevention
“Our ultimate goal is to decode how modern environments become biologically embedded to drive cancer risk, transforming prevention from broad recommendations to personalized interventions,” said Yin Cao, a molecular epidemiologist and associate professor at WashU Medicine. Cao’s team, part of the Cancer Grand Challenges‑funded Team PROSPECT, hopes that measures of accelerated aging could identify individuals at heightened risk while they are still healthy.
Current cancer screening guidelines largely focus on age‑based thresholds. By incorporating biological age metrics, clinicians might prioritize early‑detection strategies for younger patients whose bodies show signs of advanced aging. Such an approach could shift the focus from treating disease after it appears to intervening before it takes hold.
The work also highlights the importance of large, diverse datasets—such as the UK Biobank and All of Us program—in uncovering trends that single‑center studies might miss.
In short, the evidence points to a growing mismatch between how old people feel and how old their bodies truly are, a mismatch that may be fueling the surge in cancers diagnosed before age 55. As the scientific community continues to map these biological changes, the hope is that earlier, more precise interventions will curb the trend and improve outcomes for younger generations.